Chinese experts' consensus on diagnosis and treatment of severe and critical coronavirus disease 2019 (revised edition).
10.3760/cma.j.cn121430-20200218-00188
- Author:
CHINESE RESEARCH HOSPITAL ASSOCIATION OF CRITICAL CARE MEDICINE
1
,
2
,
3
,
4
;
YOUTH COMMITTEE OF CHINESE RESEARCH HOSPITAL ASSOCIATION OF CRITICAL CARE MEDICINE
Author Information
1. Corresponding author: Sun Tongwen, Email: suntongwen@
2. com; Zhang Xijing, Email: zhangxj918@
3. com; Yu Zhui, Email: yuzhui@whu.edu.cn; Shang You, Email: shang_you@
4. com.
- Publication Type:Journal Article
- MeSH:
Betacoronavirus;
COVID-19;
China;
Consensus;
Coronavirus;
Coronavirus Infections/therapy*;
Humans;
Pandemics;
Pneumonia, Viral/therapy*;
SARS-CoV-2
- From:
Chinese Critical Care Medicine
2020;32(3):269-274
- CountryChina
- Language:Chinese
-
Abstract:
The outbreak of coronavirus disease 2019 (COVID-19) is serious and there is no effective treatment to date. In order to reduce the mortality of severe and critical COVID-19, experts from the first-line in related fields in China were organized to analyze, discuss and summarize the diagnosis and treatment of severe and critical COVID-19 patients in Wuhan and other severe epidemic areas, and formulate the expert consensus. The first edition was released on February 22, 2020, and the revised one on March 4, 2020.
